Dietary Habits and Socio-economic Status on Menstrual Disorders among Young Females: A Study from Northern India | Chapter 4 | Research Aspects in Biological Science Vol. 7

 The most crucial stage of the female reproductive cycle, menstruation, involves numerous hormonal changes. The diet is known to have an impact on hormone production. Poor dietary habits of a girl might disrupt her menstrual cycle, leading to menstrual problems and pre-menstrual syndrome (PMS) (PMS). A cross-sectional study was conducted in the months of January through March 2013 among college-bound girls and young working women in Northern India to examine the relationship between dietary practises and socioeconomic level and menstruation disorders. Out of the 300 people polled for this study, 100 women were chosen, and they all responded to the questionnaire. The majority of women (87%) from middle socioeconomic position had higher frequency of menstruation diseases due to sedentary lifestyles and western food habits. Except for dysmenorrhea, vegetarian women had a higher prevalence of menstrual problems than non-vegetarian women. Women who did not consume a daily green salad had a greater prevalence of menorrhagia (56.25% vs. 32.69%), whereas those who did not consume a daily serving of fruits had higher rates of menorrhagia (44.68% vs. 43.40%) and oligomenorrhea (46.81% vs. 45.28%). The consumption of junk food (reported by 93% of respondents) and menstruation abnormalities were found to be positively correlated.

Author(s) Details:

Jasjit Kaur Randhawa,
Department of Zoology, Khalsa College, Amritsar - 143 005, India.

Kapila Mahajan,
Department of Zoology, Khalsa College, Amritsar - 143 005, India.

Manbir Kaur,
Department of Mathematics, Khalsa College for Women, Amritsar - 143 005, India.

Arti Gupta,
Department of Zoology, Khalsa College, Amritsar - 143 005, India.

Please see the link here: https://stm.bookpi.org/RABS-V7/article/view/8043

Hemangioma of Uterus: A Case Report | Chapter 17 | Issues and Developments in Medicine and Medical Research Vol. 6

 Uterine cavernous hemangiomas are extremely rare benign tumours that might cause gynaecological problems. They might be localised, presenting as an endometrial polyp, or they can present as a uterine mass, with expanded vascular gaps replacing the normal myometrium for the majority of the uterine wall. The imaging findings of a rare case of hemangioma in a 25-year-old non-pregnant female are presented here. A sense of fullness in the vaginal canal was reported by the patient.

Author(S) Details

P. V. Nagure
Department of Radiodiagnosis, Consultant Radiologist at Eureka Diagnostic Centre, India.

P. L. Jadhav
Department of Radiodiagnosis, D.Y. Patil Medical College, India.

V. R. Nikam
Department of Anatomy, D.Y. Patil Medical College, India.

A. D. Mane
Consulting Oncopathologist, Aster Aadhar Hospital, India.

J. K. Patil
Department of Radiodiagnosis, D.Y. Patil Medical College, India.

View Book:- https://stm.bookpi.org/IDMMR-V6/article/view/5610

Ulipristal in Fibroids: A Recent Study | Chapter 11 | Recent Developments in Medicine and Medical Research Vol. 14

 Symptomatic uterine fibroids are treated with surgery. Tranexamic acid, OC tablets, Progesterone, LNG IUS, and GnRH analogues are used as a temporary measure before to surgery. SPRMs (Selective Progesterone Receptor Modulators) are a novel family of medicines that can be used in medicine. Ulipristal acetate is an SPRM that has been approved for the treatment of fibroids in clinical trials.

The study was place in a tertiary care facility in South India. Fifty women with fibroids and menorrhagia who are awaiting definitive surgery or pre-operative treatment to prepare for surgery or who desire medical treatment are the study's participants. At the start of treatment, blood loss was measured using the PBAC scale. The number and size of the fibroids were determined using ultrasonography. Symptoms that went along with it were recorded. Uripristal acetate 5 mg was given every day for three months. Blood loss, amenorrhoea, and fibroids volume were all measured after three months of treatment. The negative impacts were recorded. Their menstrual cycle was monitored for another three months to see if it had restarted. Blood loss was reduced by 88 percent on average. 82 percent of women suffered from amenorrhoea. The fibroids' volume was reduced by 28.2 percent. There were no negative consequences. Two amenorrhic women reported experiencing hot flushes. After 30-40 days, 47 returned to menstruation, with normal or slightly reduced bleeding. Dymenorrhea and fibroids' pressure sensations were relieved. The findings of the study were compared to the findings of other investigations. A 5 mg dose of ulipristalis is just as effective as a 10 mg dose in managing menorrhagia and decreasing fibroid size.

Author(S) Details

Alla Satyanarayana Reddy
Department of Obstetrics & Gynaecology, Vinayaka Missions Medical College & Hospital, Karaikal, India.

S. Manjula
Department of Obstetrics & Gynaecology, Vinayaka Missions Medical College & Hospital, Karaikal, India and Vinayaka Mission`s Research Foundation VMRF (DU), India.

View Book:- https://stm.bookpi.org/RDMMR-V14/article/view/4990

Determination of Clinico-epidemiological Profile of Abnormal Uterine Bleeding among Women of Reproductive Age Group | Chapter 16 | Recent Developments in Medicine and Medical Research Vol. 5

 Background: In underdeveloped countries, abnormal uterine bleeding (AUB) is a common reason for women of all ages to consult a gynaecologist, and it is one of the most debilitating menstrual issues that leads to a hysterectomy. The researchers wanted to examine at the patients' clinical and demographic parameters, as well as the AUB pattern.

An observational study was conducted at the department of obstetrics and gynaecology at the DR Rammanohar Lohia institute of medical sciences in Lucknow, Uttar Pradesh, from August 2018 to July 2019. All women in their reproductive years who experienced symptoms of irregular uterine bleeding were included in the study.

The bulk of the women were between the ages of 30 and 40 (37.50 percent). The majority of the women (60 percent) had a normal BMI, and 71.66 percent of them were multiparous. 69.17 percent of the population belonged to the middle class. Menorrhagia was the most common symptom (48.3%), followed by oligomenorrhoea (18.1%), and finally polymenorrhoea (13.3%). (17.27 percent ).

Conclusions: Excessive menstrual blood loss is a common reason for women seeking medical help, and it places a pressure on medical resources. According to our findings, most women with AUB were between the ages of 30 and 40, multiparous, and had a normal BMI, indicating that they were middle-class. The most prevalent symptom was menorrhagia. The clinical and epidemiologic trends of abnormal uterine bleeding in reproductive age groups are highlighted in the following study. This is a critical aspect of these patients' treatment. More research with big sample sizes and high levels of evidence should be undertaken to provide evidence of causation in order to forecast causality.

Author (S) Details

Neetu Singh

Department of Obstetrics and Gynecology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Mariyam Faruqi

Department of Obstetrics and Gynecology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Yashodhara Pradeep

Department of Obstetrics and Gynecology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Shweta Bhatia

Department of Obstetrics and Gynecology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

View Book :- https://stm.bookpi.org/RDMMR-V5/article/view/4214